Streetbeat News

Products Services

CELTF

Centamin PLC (OTCPK: CELTF), a gold mining company operating in Egypt, reported a 25% increase in annual profit for 2023, reaching $195.1 million, driven by higher gold sales volume and prices. The company's revenue rose by 13% to $891.3 million, with gold sales from the Sukari mine increasing by 4% to 456,625 ounces. Despite these gains, Egypt's economic challenges and geopolitical instability pose risks to Centamin's operations.

Portfolio Pulse from Stjepan Kalinic

March 21, 2024 | 10:06 pm

NKLA

Nikola Corporation announced the grand opening of its first HYLA high-pressure modular refueling station and facility in Southern California, marking a significant milestone in the company's expansion and commitment to hydrogen fuel infrastructure.

Portfolio Pulse from Benzinga Newsdesk

March 21, 2024 | 10:02 pm

DOGE-USD

Dogecoin (DOGE) saw a 6% gain in a single day, with whales purchasing 25 million DOGE over three days, valued at $3.75 million. Technical analysis and IntoTheBlock data indicate increased activity and optimism, with transactions over $1 million up 600% in the past month. Coinbase Derivatives plans to introduce cash-settled futures for Dogecoin, Litecoin, and Bitcoin Cash, further boosting sentiment. The meme coin's price correlation with Bitcoin and its potential breakout are closely watched by traders.

Portfolio Pulse from Khyathi Dalal

March 21, 2024 | 9:51 pm

QTRX

Quanterix is inviting laboratories to explore partnership opportunities for Alzheimer's disease testing, focusing on Tau protein measurement using its patented technique under U.S. Patent No. 11,275,092.

Portfolio Pulse from Benzinga Newsdesk

March 21, 2024 | 9:32 pm

AEE

Ameren Missouri, a subsidiary of Ameren Corporation (AEE), has received approval to build or acquire around 400 megawatts of solar energy. The first solar project is expected to be operational in 2025, followed by two additional projects in 2026.

Portfolio Pulse from Benzinga Newsdesk

March 21, 2024 | 8:48 pm

MSFT

Blizzard Entertainment, a division of Microsoft Corp. (NASDAQ:MSFT), has announced the delay of Diablo 4 Season 4 to May 14, 2024, to incorporate player feedback from the Public Test Realm (PTR). The PTR will run from April 2 to April 9, and the delay will extend Season 3 by an additional month. The PTR will be exclusive to PC Battle.Net users, and Diablo 4 will join Xbox Game Pass on March 28.

Portfolio Pulse from Franca Quarneti

March 21, 2024 | 8:44 pm

ALSN

Allison Transmission (ALSN) and Yutong Bus Co., Ltd. are expanding their presence in Rwanda by exporting transit buses equipped with Allison's fully automatic transmissions. A new authorized service location in Rwanda will support Allison's growth in the region. This expansion is part of Allison's global strategy, which includes forming service partnerships worldwide, such as with Penske in Australia and Polska Grupa Zbrojeniowa in Europe.

Portfolio Pulse from Benzinga Newsdesk

March 21, 2024 | 8:32 pm

PPTA

Perpetua Resources Corp. (NASDAQ:PPTA) has sold a silver royalty from its Stibnite Gold Project to Franco-Nevada for $8.5 million. This deal enhances Perpetua's liquidity, complementing funding from the Department of Defense, and supports its efforts to advance permitting and construction readiness. The transaction is part of Perpetua's strategy to minimize equity dilution while securing non-dilutive capital for the project, which aims to re-establish a U.S. source of the critical mineral antimony.

Portfolio Pulse from Benzinga Newsdesk

March 21, 2024 | 8:31 pm

NKE

Nike Inc (NYSE:NKE) reported Q3 earnings with a revenue of $12.429 billion, surpassing the consensus estimate of $12.281 billion. Adjusted EPS was 98 cents, beating the estimate of 74 cents. Nike Direct revenue was $5.4 billion, while Nike Brand Digital sales dropped by 3%. Wholesale revenue increased by 3% to $6.6 billion. Converse brand revenue fell by 19% to $495 million. The company ended the quarter with $10.6 billion in cash and equivalents. CEO John Donahoe emphasized adjustments for growth and innovation.

Portfolio Pulse from Chris Katje

March 21, 2024 | 8:28 pm

EVOK

Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical company, announced the promotion of Matthew J. D'Onofrio to CEO, effective March 31, 2024, succeeding David A. Gonyer. D'Onofrio, currently President and COO, aims to continue the company's focus on GIMOTI® nasal spray for gastrointestinal diseases. The leadership transition is expected to maintain the company's strategic direction and commercial goals.

Portfolio Pulse from Benzinga Newsdesk

March 21, 2024 | 8:28 pm